Guangjun Nie

Active 2002–2026

207
Papers
26,571
Citations
91
h-index
191
i10-index

Citations

Citations per year for Guangjun Nie2002: 1 citations2003: 4 citations2004: 10 citations2005: 13 citations2006: 12 citations2007: 8 citations2008: 14 citations2009: 12 citations2010: 19 citations2011: 24 citations2012: 70 citations2013: 76 citations2014: 108 citations2015: 147 citations2016: 149 citations2017: 243 citations2018: 327 citations2019: 923 citations2020: 1,252 citations2021: 1,562 citations2022: 1,666 citations2023: 1,705 citations2024: 2,582 citations2025: 1,616 citations2026: 43 citations

Citation sources

Countries

World map of the countries and regions citing this authorChina: 6,388 citing papers, 43.8% of this breakdownUnited States: 2,007 citing papers, 13.7% of this breakdownIndia: 529 citing papers, 3.6% of this breakdownSouth Korea: 377 citing papers, 2.6% of this breakdownUnited Kingdom: 351 citing papers, 2.4% of this breakdownAustralia: 346 citing papers, 2.4% of this breakdownIran: 329 citing papers, 2.3% of this breakdownItaly: 310 citing papers, 2.1% of this breakdownGermany: 306 citing papers, 2.1% of this breakdownSingapore: 216 citing papers, 1.5% of this breakdownCanada: 205 citing papers, 1.4% of this breakdownJapan: 190 citing papers, 1.3% of this breakdown
0%43.8%Other 20.8%

Fields

  • Biochemistry, Genetics and Molecular Biology39%
  • Medicine16.9%
  • Engineering15.6%
  • Materials Science14.1%
  • Immunology and Microbiology7.4%
  • Pharmacology, Toxicology and Pharmaceutics2%
  • Other5%

Topics

  • Nanoplatforms for cancer theranostics9%
  • RNA Interference and Gene Delivery7.6%
  • Extracellular vesicles in disease7%
  • Advanced biosensing and bioanalysis techniques5.8%
  • Nanoparticle-Based Drug Delivery5.2%
  • MicroRNA in disease regulation3.5%
  • Other61.9%

Coauthors

All papers

Open in search
  1. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy

    Authors: , , , , , , , - Biomaterials 2013 cited by 1,777

  2. A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo

    Authors: , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2018 cited by 1,489

  3. Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology

    Authors: , , , , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 450

  4. A DNA nanodevice-based vaccine for cancer immunotherapy

    Authors: , , , , , , , , , , , , - Nature Materials 2020 cited by 542

  5. Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines

    Authors: , , , , , , , , , , , , , , , - Nature Nanotechnology 2023 cited by 230

  6. Rapid Surface Display of mRNA Antigens by Bacteria‐Derived Outer Membrane Vesicles for a Personalized Tumor Vaccine

    Authors: , , , , , , , , , , , , , , - Advanced Materials 2022 cited by 237

  7. Antigen-bearing outer membrane vesicles as tumour vaccines produced in situ by ingested genetically engineered bacteria

    Authors: , , , , , , , , , , - Nature Biomedical Engineering 2022 cited by 250

  8. Multifunctional biomolecule nanostructures for cancer therapy

    Authors: , , - Nature Reviews Materials 2021 cited by 475

  9. Design of Diselenide-Bridged Hyaluronic Acid Nano-antioxidant for Efficient ROS Scavenging to Relieve Colitis

    Authors: , , , , , , , , - ACS Nano 2022 cited by 256

  10. Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic field

    Authors: , , , , , , , , , , , , , , - Nature Communications 2023 cited by 222

  11. Engineered Bacterial Outer Membrane Vesicles as Controllable Two‐Way Adaptors to Activate Macrophage Phagocytosis for Improved Tumor Immunotherapy

    Authors: , , , , , , , , , , , , - Advanced Materials 2022 cited by 197

  12. Probiotic‐Inspired Nanomedicine Restores Intestinal Homeostasis in Colitis by Regulating Redox Balance, Immune Responses, and the Gut Microbiome

    Authors: , , , , , , , , , , - Advanced Materials 2022 cited by 173

  13. Bacterial Outer Membrane Vesicles Presenting Programmed Death 1 for Improved Cancer Immunotherapy via Immune Activation and Checkpoint Inhibition

    Authors: , , , , , , , , , , , , , , - ACS Nano 2020 cited by 271

  14. Bacteria-derived nanovesicles enhance tumour vaccination by trained immunity

    Authors: , , , , , , , , , , , , , , , - Nature Nanotechnology 2023 cited by 158

  15. Coordination-Driven Self-Assembly Strategy-Activated Cu Single-Atom Nanozymes for Catalytic Tumor-Specific Therapy

    Authors: , , , , , , , , , , , , , - Journal of the American Chemical Society 2023 cited by 252

  16. Bacterial cytoplasmic membranes synergistically enhance the antitumor activity of autologous cancer vaccines

    Authors: , , , , , , , , , , , , , , , , , - Science Translational Medicine 2021 cited by 233

  17. Nanocarriers based on bacterial membrane materials for cancer vaccine delivery

    Authors: , , - Nature Protocols 2022 cited by 181

  18. Antigen Capture and Immune Modulation by Bacterial Outer Membrane Vesicles as In Situ Vaccine for Cancer Immunotherapy Post‐Photothermal Therapy

    Authors: , , , , , , , , , , , , - Small 2022 cited by 143

  19. Injectable Immunotherapeutic Hydrogel Containing RNA-Loaded Lipid Nanoparticles Reshapes Tumor Microenvironment for Pancreatic Cancer Therapy

    Authors: , , , , , , - Nano Letters 2022 cited by 125

  20. Biomimetic and bioinspired nano‐platforms for cancer vaccine development

    Authors: , , , - Exploration 2023 cited by 128

  21. Chondrocyte membrane–coated nanoparticles promote drug retention and halt cartilage damage in rat and canine osteoarthritis

    Authors: , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2024 cited by 121

  22. Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesicles

    Authors: , , - Advanced Drug Delivery Reviews 2021 cited by 150

  23. Reversal of pancreatic desmoplasia by re-educating stellate cells with a tumour microenvironment-activated nanosystem

    Authors: , , , , , , , , , , - Nature Communications 2018 cited by 334

  24. Engineered Nanoplatelets for Targeted Delivery of Plasminogen Activators to Reverse Thrombus in Multiple Mouse Thrombosis Models

    Authors: , , , , , , , , , , , , , , , , , - Advanced Materials 2019 cited by 239